5-Methoxyisoindoline

Catalog No.: 
ACPBZC312
CAS No.: 
127168-88-1
Molecular Formula: 
C9H11NO
Molecular Weight: 
149.19
5-Methoxyisoindoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$84.00In stockInquiry
1g96%$175.00In stockInquiry
5g96%$513.00InquiryInquiry
10g96%$762.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methoxyisoindoline
IUPAC Name5-methoxyisoindoline
MDL No.MFCD06804552
Molecular FormulaC9H11NO
Molecular Weight149.19
SMILESCOC1=CC2=C(CNC2)C=C1
InChI KeyBNBIUUBEQGUPJK-UHFFFAOYSA-N
Synonym5-METHOXY-2,3-DIHYDRO-1H-ISOINDOLE;2,3-Dihydro-5-methoxy-1H-isoindole;5-METHOXYISOINDOLINE;5-METHOXY-2,3-DIHYDRO-1H-ISOINDOL;m90100;5-METHOXYISOINDOLINE HCL;1H-Isoindole,2,3-dihydro-5-Methoxy-;5-methoxyisoindoline 5-methoxy-2,3-dihydro-1h-isoindole
CAS No.127168-88-1
PubChem CID14795872

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACPBZC312 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACPBZC312 route product structure diagram
    ACPBZC312127168-88-1In Stock
Inquiry

2. ACPBZC312 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPBZC312 route product structure diagram
    ACPBZC312127168-88-1In Stock
Inquiry

3. ACPBZC312 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPBZC312 route product structure diagram
    ACPBZC312127168-88-1In Stock
Inquiry

Comments (0)